AEON Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 20, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	30	22	268	1,395	214	-
Market Cap Growth	203.26%	-91.93%	-80.82%	553.24%	-	-
Enterprise Value	43	38	252	1,642	428	-
Last Close Price	1.20	38.88	518.40	723.60	699.12	-
PE Ratio	-	0.51	-	-	-	-
PB Ratio	-	-0.76	-1.75	-10.53	-2.49	-
Debt / Equity Ratio	-0.92	-0.45	0.00	-0.99	-1.01	-1.10
Net Debt / Equity Ratio	-0.62	-0.45	0.03	-0.92	-0.95	-0.80
Net Debt / EBITDA Ratio	-0.73	-0.47	0.09	-2.52	-2.22	-3.35
Net Debt / FCF Ratio	-0.93	-0.64	0.10	-3.40	-2.86	-5.49
Asset Turnover	-	-	-	-	-	0.04
Quick Ratio	0.72	0.00	0.40	0.12	0.25	4.81
Current Ratio	0.90	0.11	0.48	0.12	0.25	4.86
Return on Equity (ROE)	-	-	-	-	-	-968.74%
Return on Assets (ROA)	-165.52%	-348.25%	-374.77%	-351.67%	-166.73%	-15.11%
Return on Capital Employed (ROCE)	-3333.40%	252.80%	851.60%	67.50%	256.70%	-96.30%
Earnings Yield	-0.01%	194.61%	-143.76%	-3.77%	-26.05%	-
FCF Yield	-43.54%	-94.01%	-17.88%	-2.57%	-13.39%	-
Buyback Yield / Dilution	91.04%	99.25%	-3896.62%	-9.98%	-1813.85%	0.74%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q